Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
BMJ
    November 2017
  1. SHAH ASV, Sandoval Y, Noaman A, Sexter A, et al
    Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study.
    BMJ. 2017;359:j4788.
    >> Share

    October 2017
  2. HAWKES N
    Statin initiation is unrelated to cardiovascular risk score, finds study.
    BMJ. 2017;359:j4898.
    >> Share

    September 2017
  3. WISE J
    Rapid blood test could speed up myocardial infarction diagnosis.
    BMJ. 2017;358:j4502.
    >> Share

  4. MAYOR S
    Supplemental oxygen does not reduce mortality in patients with suspected myocardial infarction, finds study.
    BMJ. 2017;358:j4108.
    >> Share

    August 2017
  5. RICHARDS JB, Evans DM
    Back to school to protect against coronary heart disease?
    BMJ. 2017;358:j3849.
    >> Share

  6. TILLMANN T, Vaucher J, Okbay A, Pikhart H, et al
    Education and coronary heart disease: mendelian randomisation study.
    BMJ. 2017;358:j3542.
    >> Share

  7. MAYOR S
    Intensive cholesterol control in high risk patients can reduce cardiovascular events by 20.
    BMJ. 2017;358:j4040.
    >> Share


  8. Gliflozins and reducing cardiovascular events . . . and other stories.
    BMJ. 2017;358:j3796.
    >> Share

    July 2017
  9. DALAL F, Dalal HM, Voukalis C, Gandhi MM, et al
    Management of patients after primary percutaneous coronary intervention for myocardial infarction.
    BMJ. 2017;358:j3237.
    >> Share

  10. EVANS SJ
    Effects of NSAIDs on myocardial infarction may be overestimated.
    BMJ. 2017;358:j3176.
    >> Share

    June 2017
  11. MAYOR S
    Persistent distress increases mortality in patients with coronary artery disease, study finds.
    BMJ. 2017;357:j3094.
    >> Share

  12. CAO B, Bray F, Beltran-Sanchez H, Ginsburg O, et al
    Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010.
    BMJ. 2017;357:j2765.
    >> Share

  13. CAFFERTY FH, Langley RE
    Polypill is not just for cardiovascular disease.
    BMJ. 2017;357:j2733.
    >> Share


  14. Gliflozins and reducing cardiovascular events . . . and other stories.
    BMJ. 2017;357:j2677.
    >> Share

    May 2017
  15. HIPPISLEY-COX J, Coupland C, Brindle P
    Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    BMJ. 2017;357:j2099.
    >> Share

  16. MAYOR S
    Patients with severe mental illness have greatly increased cardiovascular risk, study finds.
    BMJ. 2017;357:j2339.
    >> Share

  17. BALLY M, Dendukuri N, Rich B, Nadeau L, et al
    Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.
    BMJ. 2017;357:j1909.
    >> Share

  18. LEBWOHL B, Cao Y, Zong G, Hu FB, et al
    Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study.
    BMJ. 2017;357:j1892.
    >> Share

    April 2017
  19. CELIS-MORALES CA, Lyall DM, Welsh P, Anderson J, et al
    Association between active commuting and incident cardiovascular disease, cancer, and mortality: prospective cohort study.
    BMJ. 2017;357:j1456.
    >> Share

  20. WISE J
    Restrictions on trans fatty acids are linked to fall in cardiovascular events.
    BMJ. 2017;357:j1858.
    >> Share

  21. MISRA A, Tandon N, Ebrahim S, Sattar N, et al
    Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions.
    BMJ. 2017;357:j1420.
    >> Share

  22. JORDAN KP, Timmis A, Croft P, van der Windt DA, et al
    Prognosis of undiagnosed chest pain: linked electronic health record cohort study.
    BMJ. 2017;357:j1194.
    >> Share

    March 2017
  23. BELL S, Daskalopoulou M, Rapsomaniki E, George J, et al
    Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records.
    BMJ. 2017;356:j909.
    >> Share

  24. MUKAMAL K, Lazo M
    Alcohol and cardiovascular disease.
    BMJ. 2017;356:j1340.
    >> Share

  25. MAYOR S
    Evolocumab reduces cardiovascular events in patients with heart disease, finds study.
    BMJ. 2017;356:j1394.
    >> Share

  26. KERMODE-SCOTT B
    Failure of fertility therapy is associated with increased risk of cardiovascular events.
    BMJ. 2017;356:j1293.
    >> Share

    February 2017
  27. MAYOR S
    Testosterone increases coronary artery plaque in older men but helps anaemia and bone density.
    BMJ. 2017;356:j885.
    >> Share


  28. Gout, medication, and cardiovascular risk . . . and other stories.
    BMJ. 2017;356:j726.
    >> Share

  29. MYTTON J, Evison F, Chilton PJ, Lilford RJ, et al
    Removal of all ovarian tissue versus conserving ovarian tissue at time of hysterectomy in premenopausal patients with benign disease: study using routine data and data linkage.
    BMJ. 2017;356:j372.
    >> Share

    January 2017
  30. BANGALORE S, Fakheri R, Wandel S, Toklu B, et al
    Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials.
    BMJ. 2017;356:j4.
    >> Share


  31. Higher activity in amygdala may explain how stress increases cardiovascular events.
    BMJ. 2017;356:j187.
    >> Share

    December 2016
  32. GRAY M, Wallace A, Aldridge S
    Assessment of shoulder pain for non-specialists.
    BMJ. 2016;355:i5783.
    >> Share

  33. STIGGELBOUT AM, Jukema JW, Engelhardt EE, van den Bos C, et al
    Communicating risk to patients in the emergency department.
    BMJ. 2016;355:i6437.
    >> Share

  34. HESS EP, Hollander JE, Schaffer JT, Kline JA, et al
    Shared decision making in patients with low risk chest pain: prospective randomized pragmatic trial.
    BMJ. 2016;355:i6165.
    >> Share

  35. WISE J
    NICE advises routine high sensitivity troponin tests to rule out MI.
    BMJ. 2016;355:i6503.
    >> Share

    November 2016
  36. WISE J
    Swimming, aerobics, and racquet sports are linked to lowest risk of cardiovascular death.
    BMJ. 2016;355:i6435.
    >> Share


  37. Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial.
    BMJ. 2016;355:i6420.
    >> Share

  38. OTTO CM
    Statins for primary prevention of cardiovascular disease.
    BMJ. 2016;355:i6334.
    >> Share

  39. ZONG G, Li Y, Wanders AJ, Alssema M, et al
    Intake of individual saturated fatty acids and risk of coronary heart disease in US men and women: two prospective longitudinal cohort studies.
    BMJ. 2016;355:i5796.
    >> Share

  40. HUANG Y, Cai X, Mai W, Li M, et al
    Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis.
    BMJ. 2016;355:i5953.
    >> Share

  41. SUKKAR L, Hong D, Wong MG, Badve SV, et al
    Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis.
    BMJ. 2016;355:i5599.
    >> Share

  42. GARGIULO G, Windecker S, da Costa BR, Feres F, et al
    Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials.
    BMJ. 2016;355:i5483.
    >> Share

    October 2016
  43. DEWEY M, Rief M, Martus P, Kendziora B, et al
    Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial.
    BMJ. 2016;355:i5441.
    >> Share

  44. TOWNEND JN, Ludman PF, Doshi SN, Khan H, et al
    Assessing flow limitation in patients with stable coronary artery disease.
    BMJ. 2016;355:i5534.
    >> Share


  45. beta blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.
    BMJ. 2016;355:i5602.
    >> Share


  46. Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.
    BMJ. 2016;355:i5600.
    >> Share

  47. WISE J
    Eating oats reduces three markers of cardiovascular risk, finds study.
    BMJ. 2016;355:i5475.
    >> Share

    September 2016
  48. JOHNSON LR
    Current physical activity guidance is misinterpreted.
    BMJ. 2016;354:i4811.
    >> Share

  49. MAYOR S
    Invasive coronary strategy improves survival after MI, shows UK study.
    BMJ. 2016;354:i4783.
    >> Share

    August 2016
  50. WISE J
    Sexual problems are common in under 55s after acute MI, study finds.
    BMJ. 2016;354:i4737.
    >> Share

  51. MAYOR S
    Acute MI is initially misdiagnosed in nearly a third of patients, study finds.
    BMJ. 2016;354:i4713.
    >> Share

  52. KMIETOWICZ Z
    NICE recommends 3D heart imaging for diagnosing heart disease.
    BMJ. 2016;354:i4662.
    >> Share

  53. WISE J
    NICE recommends ticagrelor with aspirin for three years post-MI.
    BMJ. 2016;354:i4438.
    >> Share

    June 2016
  54. DUKES JW, Dewland TA, Vittinghoff E, Olgin JE, et al
    Access to alcohol and heart disease among patients in hospital: observational cohort study using differences in alcohol sales laws.
    BMJ. 2016;353:i2714.
    >> Share

    May 2016
  55. FIGUEROA JF, Tsugawa Y, Zheng J, Orav EJ, et al
    Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study.
    BMJ. 2016;353:i2214.
    >> Share

    January 2016
  56. WISE J
    Many people receive suboptimal care after myocardial infarction, research shows.
    BMJ. 2016;353:i2655.
    >> Share

  57. DAM MK, Hvidtfeldt UA, Tjonneland A, Overvad K, et al
    Five year change in alcohol intake and risk of breast cancer and coronary heart disease among postmenopausal women: prospective cohort study.
    BMJ. 2016;353:i2314.
    >> Share

  58. WEILL A, Dalichampt M, Raguideau F, Ricordeau P, et al
    Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.
    BMJ. 2016;353:i2002.
    >> Share

  59. MAYOR S
    Ticagrelor is no better than aspirin at preventing cardiovascular events after acute stroke or TIA, study finds.
    BMJ. 2016;353:i2654.
    >> Share

  60. WISE J
    Cardiovascular MRI is better than standard scan, say researchers.
    BMJ. 2016;353:i2592.
    >> Share

  61. HOLT T
    Predicting cardiovascular disease.
    BMJ. 2016;353:i2621.
    >> Share

  62. DAMEN JA, Hooft L, Schuit E, Debray TP, et al
    Prediction models for cardiovascular disease risk in the general population: systematic review.
    BMJ. 2016;353:i2416.
    >> Share

  63. SALISBURY C, O'Cathain A, Thomas C, Edwards L, et al
    Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial.
    BMJ. 2016;353:i2647.
    >> Share

  64. KURTH T, Winter AC, Eliassen AH, Dushkes R, et al
    Migraine and risk of cardiovascular disease in women: prospective cohort study.
    BMJ. 2016;353:i2610.
    >> Share

  65. SHIN JY, Roughead EE, Park BJ, Pratt NL, et al
    Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study.
    BMJ. 2016;353:i2550.
    >> Share

  66. JACKSON JW
    The cardiovascular safety of methylphenidate.
    BMJ. 2016;353:i2874.
    >> Share

  67. KYPRIDEMOS C, Allen K, Hickey GL, Guzman-Castillo M, et al
    Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options.
    BMJ. 2016;353:i2793.
    >> Share


  68. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study.
    BMJ. 2016;353:i3123.
    >> Share

  69. AUNE D, Keum N, Giovannucci E, Fadnes LT, et al
    Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies.
    BMJ. 2016;353:i2716.
    >> Share

  70. WAQAR S, Mughal F, Rashid A, Mant J, et al
    Assessment of cardiovascular risk in primary care.
    BMJ. 2016;353:i3022.
    >> Share

  71. TIMMIS A, Rapsomaniki E, Chung SC, Pujades-Rodriguez M, et al
    Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations.
    BMJ. 2016;353:i3163.
    >> Share

  72. MAYOR S
    Moderate LDL cholesterol reduction with statins shows similar benefit to aggressive lipid lowering in ischaemic heart disease.
    BMJ. 2016;353:i3437.
    >> Share

  73. MONTASTRUC F, Montastruc G, Montastruc JL, Revet A, et al
    Cardiovascular safety of methylphenidate should also be considered in adults.
    BMJ. 2016;353:i3418.
    >> Share


  74. Migraine and risk of cardiovascular disease in women: prospective cohort study.
    BMJ. 2016;353:i3411.
    >> Share

  75. WISE J
    Moderate physical activity in older adults is not associated with reduced cardiovascular events.
    BMJ. 2016;353:i3639.
    >> Share

  76. GALLIVER M
    Media coverage of statins may have led to 2000 cardiovascular events.
    BMJ. 2016;353:i3630.
    >> Share

  77. MAYOR S
    High cholesterol diet is not linked to increased heart risk, study shows.
    BMJ. 2016;352:i919.
    >> Share

  78. HIPPISLEY-COX J, Coupland C
    Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
    BMJ. 2016;354:i3477.
    >> Share

  79. WISE J
    Flu vaccination reduces hospital admissions for cardiovascular disease in people with diabetes, study shows.
    BMJ. 2016;354:i4130.
    >> Share

  80. KYU HH, Bachman VF, Alexander LT, Mumford JE, et al
    Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013.
    BMJ. 2016;354:i3857.
    >> Share

  81. WHITTLE J
    Blood pressure variability and cardiovascular risk.
    BMJ. 2016;354:i4190.
    >> Share

  82. STEVENS SL, Wood S, Koshiaris C, Law K, et al
    Blood pressure variability and cardiovascular disease: systematic review and meta-analysis.
    BMJ. 2016;354:i4098.
    >> Share

  83. ADAMSSON ERYD S, Gudbjornsdottir S, Manhem K, Rosengren A, et al
    Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.
    BMJ. 2016;354:i4070.
    >> Share

  84. WISE J
    Long term marijuana use is linked to impaired verbal memory.
    BMJ. 2016;352:i619.
    >> Share

  85. WOODWARD M
    On validation of cardiovascular risk scores.
    BMJ. 2016;354:i4483.
    >> Share

  86. RAMSDEN CE, Zamora D, Majchrzak-Hong S, Faurot KR, et al
    Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73).
    BMJ. 2016;353:i1246.
    >> Share

  87. MAYOR S
    Cardiovascular and death risks are lower if parents live longer, show UK data.
    BMJ. 2016;354:i4537.
    >> Share


  88. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study.
    BMJ. 2016;354:i4840.
    >> Share

  89. ODUTAYO A, Wong CX, Hsiao AJ, Hopewell S, et al
    Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
    BMJ. 2016;354:i4482.
    >> Share

  90. ELDER A, Japp A, Verghese A
    How valuable is physical examination of the cardiovascular system?
    BMJ. 2016;354:i3309.
    >> Share

  91. PUYMIRAT E, Riant E, Aissoui N, Soria A, et al
    beta blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.
    BMJ. 2016;354:i4801.
    >> Share

  92. MAYOR S
    Early menopause is linked to higher risk of cardiovascular disease and death, review finds.
    BMJ. 2016;354:i5004.
    >> Share

  93. LEONARDI S, Frigoli E, Rothenbuhler M, Navarese E, et al
    Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial.
    BMJ. 2016;354:i4935.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016